Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2025-12-24 @ 4:54 PM
NCT ID:
NCT02980250
Eligibility Criteria:
Inclusion Criteria:
* the residual milk and glucose over 55%
* abdominal distention or vomiting;
* Reduce,delay or disruption of enteral feeding
Exclusion Criteria:
* Four weeks before the start of this study had participated in other clinical trials
* pulmonary hypertension;
* Infants with necrotizing enterocolitis
* Gastrointestinal tract malformation, congenital heart disease
* Pre-existing QT extend/between long QT syndrome;
* ascites
* Have been used or will use drugs suppress CYP3A4
* Other risk factors for prolong the QT
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Weeks
Maximum Age:
35 Weeks
Study:
NCT02980250
Study Brief:
Protocol Section:
NCT02980250